Vivos Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Vivos Therapeutics, Inc. (VVOS) reported Earnings Per Share, Basic and Diluted of -$0.96 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-31
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.32.
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.26.
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.19.
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.19.
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.96.
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.40.
- Vivos Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.95.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.96 10-K · filed 2022-03-31 |
| 2021-09-30 | -$0.26 10-Q · filed 2021-11-15 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-12-20 | -$0.62 10-Q · filed 2021-11-15 | -$1.32 derived: net income ÷ weighted average shares · filed 2022-12-20 |
| 2021-06-30 | -$0.19 10-Q · filed 2021-08-12 | -$0.38 10-Q · filed 2021-08-12 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-12-20 | -$1.28 derived: net income ÷ weighted average shares · filed 2022-12-20 |
| 2021-03-31 | -$0.19 10-Q · filed 2021-05-17 | -$0.93 derived: net income ÷ weighted average shares · filed 2022-11-25 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-11-25 | -$1.30 derived: net income ÷ weighted average shares · filed 2022-11-25 |
| 2020-12-31 | -$0.83 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.03 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.17 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.40 10-K · filed 2022-03-31 |
| 2020-09-30 | -$0.17 10-Q · filed 2021-11-15 | -$0.30 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.52 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$0.13 10-Q · filed 2021-08-12 | -$0.36 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$0.23 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$0.95 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |